Harry Kovelman Sells Shares of Myomo, Inc. $MYO

Key Points

  • Harry Kovelman sold 10,442 shares of Myomo, Inc. ($MYO) worth $12,530.
  • $MYO last traded around $1.15.

Harry Kovelman, Chief Medical Officer at Myomo, Inc. ($MYO), sold 10,442 shares at an average price of $1.20, for a total transaction of $12,530. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

Myomo, Inc. ($MYO) Stock

Last price$1.15
Market cap$44.43M
Forward P/E-4.54
Beta1.46
52-week low$0.60
52-week high$2.89
50-day MA$0.93
200-day MA$0.91
Current ratio2.73
Quick ratio2.19
Debt-to-equity2.11

Myomo, Inc. Earnings

EPS (ttm)$-0.36
Revenue (ttm)$41.21M
Revenue growth2.9%
Net margin-36.7%
Return on equity-98.5%
Next earningsAug 10, 2026

Analysts Set New Price Targets

ConsensusStrong Buy
Average target$4.42
High target$10.00
Low target$1.10
Analysts covering5

About Myomo, Inc.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

ExchangeNYSE American
SectorHealthcare
IndustryMedical Devices
HeadquartersBurlington, MA
CEOMr. Paul R. Gudonis
Employees194

See Also

This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.